Navigation Links
Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results
Date:11/4/2009

iability.

Use of Non-GAAP Measures

To supplement our consolidated financial statements presented in accordance with GAAP, we use the following measures defined as non-GAAP financial measures by the SEC: non-GAAP net loss and non-GAAP loss per basic and diluted share. The presentation of this financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP. In addition, the non-GAAP financial measures included in this press release may be different from, and therefore not comparable to, similar measures used by other companies. Although certain non-GAAP financial measures used in this release exclude the accounting treatment of valuation adjustments associated with our outstanding warrants to purchase shares of our common stock, these non-GAAP measures should not be relied upon independently.

Our management believes that these non-GAAP financial measures provide meaningful supplemental information regarding our performance by excluding certain expenses and expenditures that may not be indicative of our core business operating results. We believe that both management and investors benefit from referring to these non-GAAP financial measures in assessing our performance and when planning, forecasting and analyzing future periods. These non-GAAP financial measures also facilitate management's internal comparisons to our historical performance and our competitors' operating results. We believe that these non-GAAP measures are useful to investors in allowing for greater transparency with respect to supplemental information used by management in its financial and operational decision making.

CONFERENCE CALL INFORMATION

Savient's management team will host a live conference call and Webcast on Thursday, November 5 at 10:00 a.m. Eastern Time/7:00 a.m. Pacific Time to review the third quarter financial re
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Savient Announces FDAs Advisory Panel to Review Pegloticase for Treatment-Failure Gout Patients
2. Savient Provides Update on Pegloticase BLA
3. Savient Pharmaceuticals Announces Proposed Public Offering of Common Stock
4. Savient Pharmaceuticals Prices Underwritten Offering of Common Stock
5. Savient Pharmaceuticals Announces Closing of Public Offering and Exercise of Over-Allotment Option
6. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
8. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
9. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
10. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
11. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... MOUNTAIN VIEW, Calif., Dec. 16 ChemoCentryx, ... patients in a Phase 2 clinical trial of ... to specifically target the CCR1 chemokine receptor for ... CCX354 is a highly potent and selective antagonist ... recruitment of immune cells, such as monocytes and ...
(Date:12/16/2009)... , - MIVI-TRUST ... Total of Over,640 patients Ahead of Schedule ... (Euronext Brussels: THR), a biopharmaceutical company,focused on ... for eye,disease, vascular disease and cancer, announces ... the second Phase III trial evaluating microplasmin ...
(Date:12/15/2009)... Corporation (Nasdaq: VOLC ), a leading developer ... Fractional Flow Reserve (FFR), Intravascular Ultrasound (IVUS), Forward ... designed to enhance the diagnosis and treatment of ... placement of over 2,500 s5 family consoles worldwide. ... launched in April 2006, with more than 1,000 ...
Breaking Medicine Technology:ChemoCentryx Initiates Phase 2 Clinical Trial of CCX354 for the Treatment of Rheumatoid Arthritis 2ChemoCentryx Initiates Phase 2 Clinical Trial of CCX354 for the Treatment of Rheumatoid Arthritis 3ChemoCentryx Initiates Phase 2 Clinical Trial of CCX354 for the Treatment of Rheumatoid Arthritis 4ChemoCentryx Initiates Phase 2 Clinical Trial of CCX354 for the Treatment of Rheumatoid Arthritis 5ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 2ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 3ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 4Volcano Announces Installed Base Growth Milestone 2Volcano Announces Installed Base Growth Milestone 3Volcano Announces Installed Base Growth Milestone 4Volcano Announces Installed Base Growth Milestone 5Internationally Renowned Bariatric and Laparoscopic Surgeons To Meet in San Diego 5767 1Internationally Renowned Bariatric and Laparoscopic Surgeons To Meet in San Diego 5767 2Onyx Pharmaceuticals Announces Third Quarter 2009 Financial Results Teleconference and Webcast 5763 1STAAR Surgical Announces Third Quarter 2009 Earnings Release Date and Conference Call 5759 1STAAR Surgical Announces Third Quarter 2009 Earnings Release Date and Conference Call 5759 2
(Date:12/16/2009)... for your loved ones this holiday season, give them the gift ... running, child care, and pet care through Delegate Source. , ... ... the Denver and Boulder metro areas have the opportunity to give ... by using Delegate Source,s " Give a Gift " program to ...
(Date:12/15/2009)... Watchdog Calls For Preserving State Authority, Ban on ... ,, WASHINGTON, Dec. 15 Consumer Watchdog ... for those over 55 and the public option ... the group said that the Senate must still ... bill to prevent ceding the entire health care ...
(Date:12/15/2009)... lump of coal for lying about taxes in the healthcare ... Max Baucus has earned a place under the "Naughty" column ... List after being caught telling a brazen lie on ... Senate healthcare bill would not raise taxes. ,, Speaking ... ,, " I have also ...
(Date:12/15/2009)... of reproductive age were evaluated, Italian study found , , ... children born with cystic fibrosis decreases when screening for ... a new study finds. , CF neonatal screening has ... many years. Since the 1990s, the area has seen ... born with CF. , Two different CF carrier detection ...
(Date:12/15/2009)... Association and the CDC have released some sobering statistics concerning the ... Treadmill desks offer employers an effective means of combating this trend ... ... 14, 2009 -- Rates of diabetes are climbing across America due ... Despite this rise the American Diabetes Association has stated that the ...
Breaking Medicine News(10 mins):Health News:Give the Gift of Service This Holiday Season with Delegate Source 2Health News:Give the Gift of Service This Holiday Season with Delegate Source 3Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 2Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 3Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 4Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 5Health News:ATR: Baucus Earns Place on 2009 "Naughty" List 2Health News:ATR: Baucus Earns Place on 2009 "Naughty" List 3Health News:Wider Adult Screening May Mean Fewer Children With Cystic Fibrosis 2Health News:TrekDesk: A Potentially Positive Impact on Diabetes & Obesity 2Health News:TrekDesk: A Potentially Positive Impact on Diabetes & Obesity 3
... Researchers has found that babies that were born prematurely ... hyperactive, with low attention spans, at later stages//. ... times as likely to become hyperactive, with low attention ... Archives of Disease in Childhood. ,Hyperactivity, low ...
... a controversial bill on the 'national food uniformity'. This ... from local & state governments to enforce labels on ... to cause cancer, defects in birth, allergy reactions or ... in California and other states. The bill would also ...
... a Nigerian national and recovered 41 grams of cocaine ... information that Michael //Ofori Danagogo alias Mike, who was ... visit Motibagh area in south Delhi in the night ... trap and arrested him., ,He has been booked ...
... to a month's imprisonment last month by ... today underwent an angiography at a private ... JJ Hospital, where Naik was admitted immediately ... pain, said he underwent the medical procedure ...
... New Delhi, Jun 5. Observing that breast feeding alone can ... governments to launch awareness campaigns //on breast feeding on the ... alone can reduce infant mortality rates by 13 per cent. ... but also ensures a strong foundation for good health throughout ...
... the use of inhaler in patients suffering from mild ... techniques //on symptoms, lung function, use of medication and ... reported the science portal EurekAlert. ,The first ... and the second technique used general upper body exercises, ...
Other Medicine News:Health News:Association Asks People To Tell Their Senator To Vote against The "National Food Uniformity Act" 2
9" X 14" Translucent plastic may be used with illuminated test cabinets or as a wall chart 20/100 to 20/10....
Wilbrandt-binkhorst irrigating cannula....
McIntyre-Binkhorst Cannula have a smooth blunt tip end opening....
Wire lid retractor may be clamped to surgical drape with suture or elastic band. Large pair....
Medicine Products: